Announcements and Notices - [Announcement by Offeror Company under the Takeovers Code / Announcement by Offeree Company under the Takeovers Code]

YiChang HEC ChangJiang Pharmaceutical Co Ltd develops a variety of drugs.  The Company develops and sells drugs for anti-virus, metabolic diseases, cardiovascular, and more.

Sunshine Lake Pharma Co., Ltd. To Enter Into A Licensing Agreement With Apollo To Develop And Commercialise Apl-18881 (Hec88473) , A Fgf21 / Glp-1 Dual Receptor Agonist

Joint Announcement
Monthly Update
In Relation To The Proposed Pre-Conditional Privatisation
Of Yichang Hec Changjiang Pharmaceutical Co., Ltd.
By Sunshine Lake Pharma Co., Ltd.
By Way Of Merger By Absorption Of
Yichang Hec Changjiang Pharmaceutical Co., Ltd.

Articles Of Association

Announcements and Notices - [Results of EGM/SGM / Continuing Connected Transaction / Amendment of Constitutional Documents]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Yichang HEC Changjiang Pharma (1558 HK)

Sunshine Lake Pharma Co., Ltd. To Enter Into A Licensing Agreement With Apollo To Develop And Commercialise Apl-18881 (Hec88473) , A Fgf21 / Glp-1 Dual Receptor Agonist

Joint Announcement Monthly Update In Relation To The Proposed Pre-Conditional Privatisation Of Yichang Hec Changjiang Pharmaceutical Co., Ltd. By Sunshine Lake Pharma Co., Ltd. By Way Of Merger By Absorption Of Yichang Hec Changjiang Pharmaceutical Co., Ltd.

Articles Of Association

Poll Results Of 2024 First Extraordinary General Meeting Held On 31 October 2024

Document On Display

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)